Physician profile
John J Eck
NPI 1033148044
$602.38
in general payments reported to CMS, 2019-2025
21 companies · $16.64 in 2025
The $16.64 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $118 · 2021: $141 · 2022: $123 · 2025: $16.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $70.81 | 2021 | |
| Abbvie INC. | $70.28 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $54.83 | 2019-2020 | |
| Lilly USA, LLC | $50.17 | 2019-2022 | |
| Therapeuticsmd, INC. | $48.52 | 2019-2020 | |
| Novo Nordisk INC | $36.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $32.95 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.05 | 2022 | |
| Pfizer INC. | $26.71 | 2019-2020 | |
| Allergan, INC. | $24.83 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.13 | 2019 | |
| Recordati_rare_diseases_inc. | $16.64 | 2025 | Isturisa |
| Biodelivery Sciences International, INC. | $16.37 | 2019 | |
| Antares Pharma, INC. | $15.70 | 2019 | |
| Adlon Therapeutics L.P. | $15.15 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.83 | 2019 | |
| Amgen INC. | $14.16 | 2019 | |
| Glaxosmithkline, LLC. | $14.09 | 2021 | |
| Exeltis, USA INC. | $13.92 | 2022 | |
| Esperion Therapeutics, INC. | $11.36 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Eck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.